Skip to content
2000
Volume 6, Issue 5
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Two hydrolytically activated anthraquinone-diclofenac prodrugs have been designed and synthesized. Both prodrugs show significant binding capability to hydroxyapative (HAP), the major component of bone, and hydrolytically activity in simulation physiological conditions in vitro.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180810906050393
2009-07-01
2025-09-04
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180810906050393
Loading

  • Article Type:
    Research Article
Keyword(s): Anthraquinone; Anti-inflammatory; Bone affinity; Bone-targeting; Hydrolytic; Prodrug
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test